Moderna shares sink after leaked cancer data missed expectations
Melanoma vaccine treatment cut risk of recurrence or death by 58% but failed to exceed Wall Street’s lofty expectations
Óptica: sourceFuente: Financial Times. Publicación automática del contenido provisto por su canal RSS; sin reelaboración factual de SUR NODAL.
Abrir la fuente originalMelanoma vaccine treatment cut risk of recurrence or death by 58% but failed to exceed Wall Street’s lofty expectations